To advance academic exchanges in chronic kidney disease (CKD) research, standardize clinical practices, and enhance Chinese nephrologists 'expertise in managing CKD and its complications (including renal anemia), the  "CKD Academic Symposium" hosted by Chengdu High-Tech Medical Association was successfully held on June 25,2025. The event brought together leading experts from global nephrology communities to discuss current treatment paradigms, strategies for managing renal anemia, and cutting-edge precision medicine advancements. By integrating these insights with China's clinical context, participants collaborated to develop optimal treatment protocols that will benefit patients worldwide.

    Chronic kidney disease (CKD) constitutes a global public health challenge, with its complications like renal anemia severely impacting patients‘ quality of life and prognosis.  Driven by rapid advancements in medical science, CKD management paradigms have evolved, making personalized and precision-based therapies the new norm.  This symposium focuses on two core themes “Comprehensive CKD Management” and “Precision Treatment for Renal Anemia.” Through expert-led presentations, case studies, and clinical evaluations, the event provides in-depth analysis of international guidelines and shares practical insights to enhance CKD care standards in China.  The conference features keynote speeches from renowned nephrology specialists, hematologists, and clinical researchers within the province, showcasing cutting-edge research findings and real-world clinical experiences.